KRAS Mutations in Peripheral Blood (with or without CA19-9) for Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis: a Systematic Review and Meta-analysis
- 9 July 2022
- journal article
- review article
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (4) , 615-622
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Detection of K‐ras gene mutation by liquid biopsy in patients with pancreatic cancerCancer, 2015
- Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individualsWorld Journal of Gastrointestinal Endoscopy, 2015
- Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitisWorld Journal of Gastroenterology, 2015
- Pancreatic AdenocarcinomaNew England Journal of Medicine, 2014
- K-rasMutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-AnalysisDisease Markers, 2014
- Quantifying the impact of between‐study heterogeneity in multivariate meta‐analysesStatistics in Medicine, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Follow-Up Study of K-ras Mutations in the Plasma of Patients With Pancreatic CancerPancreas, 2009
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Low Correspondence Between K-ras Mutations in Pancreatic Cancer Tissue and Detection of K-ras Mutations in Circulating DNAPancreas, 2006